Cisco Systems is implementing a restructuring plan that includes job cuts to refocus its business on high-growth areas such as AI infrastructure, silicon, optics, and security. The company anticipates up to $1 billion in restructuring costs but raised its full-year guidance due to strong quarterly earnings and revenue. This strategic shift aims to better position Cisco to capitalize on increasing demand for AI-related technologies.

Arch Capital Group shares traded around $94, influenced by recent insider sales from its director and CEO. Analysts currently hold a 'Hold' rating on the stock with an average target price of $106.32. The company, a global insurer and reinsurer, maintains a market cap of $32.95 billion and is recognized for its low volatility and strong ties to the US property and mortgage markets.

Simply Good Foods (SMPL) director David J. West reported gifting 348,000 common shares in two separate bona fide transactions on May 12, 2026. These gifts, valued at $0.00 per share, were made to an independently managed family trust for estate planning and to a charitable private foundation controlled by him and his spouse. This action reflects estate and charitable planning rather than a sale for proceeds, as confirmed by the SEC Form 4 filing.

Raymond James Financial, Inc. (NYSE: RJF) announced that its Board of Directors declared a quarterly cash dividend of $0.54 per share on its common stock. The dividend is payable on July 15, 2026, to shareholders of record as of July 1, 2026. Raymond James Financial is a diversified financial services company with total client assets of $1.76 trillion.

The Minnesota Pollution Control Agency (MPCA) has filed a new lawsuit against 3M, alleging persistent PFAS contamination from its Cottage Grove facility. The MPCA is seeking civil penalties and further cleanup, claiming 3M has not adequately addressed past contamination. 3M, in turn, argues that some pollution stems from its work for the U.S. military and has requested the case be moved to federal court.

Bank of America Corp. (BAC) has seen increased institutional interest following a strong quarterly earnings report, which included an EPS of $1.11 on $30.27 billion in revenue and a declared quarterly dividend of $0.28 per share. Virginia Retirement Systems significantly boosted its stake, reflecting confidence in the bank's diversified business model. Analysts maintain a "Moderate Buy" consensus with an average target price of $61.06, underscoring positive market sentiment for the stock.

Verisign stock (VRSN) saw a 6.67% surge on July 25, 2025, closing at $305.79, indicating a break from its short-term downtrend and triggering buy signals from moving averages. The company, which exclusively manages .com and .net domain names, benefits from a stable, high-margin business model and is supported by strong technical indicators and its position in critical internet infrastructure. This performance, along with consistent monthly gains in May 2026, highlights its technical strength and stability for investors focused on tech defensives.

Franklin Templeton (Franklin Resources) announced a strategic collaboration with Payward, the parent company of Kraken, on May 12, 2026. This partnership aims to advance tokenized assets and institutional digital offerings, signaling the asset manager's deeper engagement in the crypto market. The initiative leverages Payward's xStocks framework to provide institutional clients with access to tokenized securities and digital assets, aligning with broader industry trends towards blockchain-based investment solutions.

Boston Scientific Corp. stock recently hit a 52-week low of $53.10 despite reporting robust first-quarter 2026 revenue of $5.2 billion, an 11.6% increase year-over-year. The company specializes in developing and marketing medical devices, with strong performance in its cardiovascular and electrophysiology segments. Despite market pressures, its NYSE listing provides US investors access to the innovative medtech sector.

Bernstein analyst Lance Wilkes maintained an "Outperform" rating for CVS Health (CVS) and raised its price target from $94.00 to $106.00, representing a 12.77% increase. Despite this positive analyst sentiment, GuruFocus assesses CVS as 25.3% overvalued with a GF Value™ of $77.66 against a current price of $97.34. The company has a strong GF Score™ of 81/100, but recent insider activity shows $6.2 million in share sales over the last three months, suggesting potential insider concerns about valuation.